Palvella Therapeutics (PVLA) Shareholder's Equity (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 730.19% |
| Dec 31, 2025 | -27.66% |
| Sep 30, 2025 | -19.04% |
| Jun 30, 2025 | -14.03% |
| Mar 31, 2025 | -11.23% |
| Dec 31, 2024 | 171.63% |
| Sep 30, 2024 | -8.14% |
| Jun 30, 2024 | -5.14% |
| Mar 31, 2024 | -3.21% |
| Dec 31, 2023 | -344.13% |
| Sep 30, 2023 | -24.66% |
| Jun 30, 2023 | 161.99% |
| Mar 31, 2023 | 116.48% |
| Jun 30, 2022 | -17.00% |
| Mar 31, 2022 | 5.31% |
| Dec 31, 2021 | -5.75% |
| Sep 30, 2021 | 15.27% |
| Jun 30, 2021 | 22.19% |
| Mar 31, 2021 | 23.23% |
| Dec 31, 2020 | -28.99% |
| Sep 30, 2020 | -6.39% |
| Jun 30, 2020 | -6.29% |
| Mar 31, 2020 | -3.01% |
| Dec 31, 2019 | 148.77% |
| Sep 30, 2019 | 5.94% |
| Jun 30, 2019 | -35.40% |
| Mar 31, 2019 | -24.47% |
| Dec 31, 2018 | -20.54% |
| Sep 30, 2018 | -9.14% |
| Jun 30, 2018 | 9.12% |
| Mar 31, 2018 | 339.96% |
| Dec 31, 2017 | 152.77% |
| Sep 30, 2017 | -51.16% |
| Jun 30, 2017 | -48.25% |
| Mar 31, 2017 | -28.51% |
| Dec 31, 2016 | -19.87% |
| Sep 30, 2016 | -15.58% |
| Jun 30, 2016 | 37.22% |
| Mar 31, 2016 | -12.70% |
| Dec 31, 2015 | -7.50% |
| Sep 30, 2015 | 201.88% |
| Jun 30, 2015 | -21.65% |
| Mar 31, 2015 | -20.99% |
| Dec 31, 2014 | 1,991,960.40% |
| Sep 30, 2014 | -109.03% |
| Jun 30, 2014 | 309.59% |
| Mar 31, 2014 | -100.82% |